Iron is an essential micronutrient responsible for a whealth of biological processes of the human body. Iron plays a fundamental role especially in oxygen transport, by binding to hemoglobin in the blood circulation. Iron intake from the diet needs to be in balance the unavoidable losses that occur daily via different pathways. The recommended daily requirement of iron is based on the balance between absorption and losses and is calculated to maintain a balance so that the absorption equals losses. At higher altitudes, the absorption of iron may be higher due to adaptation mechanisms in response to low oxygen concentration, and to maintain a larger erytroid compartement. However, the long-term effects of altitude on iron balance are unknown. Filling this knowledge gap is important to better understand iron deficiency in populations living at high and moderate altitudes. Therefore, the investigators plan to study people that live at two different altitudes and measure iron absorption and losses over the long term. This will be useful to formulate specific recommendations for this population groups, to expand the knowledge base to better prevent iron deficiency in Switzerland but also worldwide. Participants will be asked to consume a dose of stable iron isotopes. After one year from isotope administration, the isotopes will be equally distributed in all body compartments and any change in the isotope abundance with the normal occurring body iron can be detected. From this point onwards, the investigators can observe the iron turnover and calculate iron absorption and losses per unit of time. At 4 different visits blood samples will be taken from each participant.
This study compares iron absorption in two population groups residing at different altitudes in Switzerland-one below 1000 meters above sea level and the other above 1500 meters. Additionally, the study aims to determine whether daily iron intake recommendations should be adjusted for high-altitude populations and to establish appropriate thresholds for diagnosing iron deficiency and iron deficiency anemia in these conditions. In each group 60 participants (30 men and 30 women) will be recruited. Each participant will be administered with an oral dose of iron isotopes in the form of ferrous sulphate 57FeSO4 dissolved in water. Ascorbic acid (vitamin C) will be additionally given with the isotope dose to increase the absorption and the enrichment in the body compartments and sirup will be added to the solution to confer a sweet flavour. There will be no other intervention throughout the course of the study. The investigators will collect blood samples during the second year from study start at a frequency of 4 months for a total of 4 visits, at months 12, 16, 20 and 24. Venous blood samples for the measurement of the isotopic signal will be collected, and at two additional study visits the investigators will also measure hemoglobin using the so-called carbon monoxide (CO) rebreathing method that includes a CO rebreathing into a closed-circuit system in combination with pure oxygen. Before and after the 6 min re-breathing, capillary blood will be collected by finger prick in triplicates. At the study visits with blood withdrawal, the investigators will ask participants to fill questionnaires about dietary intake and physical activity.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
120
15 mg of stable iron isotopes in the form of ferrous sulphate 57FeSO4 will be orally administered to each participant.
Fernfachhochschule Schweiz (FFHS)
Zurich, Canton of Zurich, Switzerland
RECRUITING57Fe tracer concentration in the circulation
The measurement of the isotopic tracer concentration in the circulation allows to calculate the lon-term iron absorption in the participants, and the rate of change of the tracer allows to calculate the rate of change of body iron.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Hemoglobin mass
Hemoglobin mass will be measured using the CO-rebreathing method. In contrast to hemoglobin concentration, hemoglobin mass is more accurate since it does not depend on blood volume.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 2 measurements for each participant.
Ferritin concentration
Ferritin concentration in serum, expressed as ug/L will be assessed as an indicator of the iron status.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Hepcidin concentration
Hepcidin concentration in serum will be measured as a parameter for the iron status.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Serum transferrin receptor concentration
The serum concentration of the transferrin receptor (TfR) will be measure as a biomarker for iron status.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Concentration of c-reactive protein (CRP)
Concentration of c-reactive protein (CRP) in mg/L will be measured in serum as a biomarker for inflammation status.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Concentration of alpha-1-acid glycoprotein (AGP)
Concentration of serum AGP will be measured as abionarker for inflammation status
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Concentration of erythropoietin
Erythropoietin (EPO) concentration in whole blood will be measured as a biomarker for erythropoiesis.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
Concentration of Erythroferrone (ERFE)
Concentration of erythroferrone in serum will be measured as a biomarker for erythropoiesis.
Time frame: 1 year after isotopic administration and every four months afterwards, for a total of 4 measurements.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.